Shabby Standards

July 25, 2008

Bryan A.  Liang, MD, PhD, JD 

Earlier this week, I talked about India's opposition to IMPACT's proposed definition of a counterfeit medicine.  Indian "experts" claimed it would hurt their generic drug industry's exports, and I asked just who these "experts" were protecting if the IMPACT's focus was only non-legitimate producers.  

[...]